本维莫德在皮肤病中的研究进展  

Benvitimod for the treatment of dermatoses

作　　者：陈良宏 孙艳[1] 王敬玉[1] 吴严 Chen Lianghong;Sun Yan;Wang Jingyu;Wu Yan(Department of Dermatology,the First Hospital of China Medical University,Shenyang 110001,China;Department of Emergency Medicine,Shengjing Hospital of China Medical University,Shenyang 110801,China)

机构地区：[1]中国医科大学附属第一医院皮肤科,沈阳110001 [2]中国医科大学附属盛京医院急诊科,沈阳110801

出　　处：《中华皮肤科杂志》2025年第3期266-268,共3页Chinese Journal of Dermatology

基　　金：国家自然科学基金(82103758)。

摘　　要：本维莫德是一种芳香烃受体激动剂,通过不同途径抑制各种炎症因子的表达,对银屑病、特应性皮炎、白癜风、接触性皮炎及玫瑰痤疮等炎症性皮肤病起到一定的治疗作用。本文总结分析本维莫德在皮肤病中的研究进展,以期加深对本维莫德生物效应的认识。Benvitimod is an aryl hydrocarbon receptor agonist,and has a certain therapeutic effect on some inflammatory dermatoses,such as psoriasis,atopic dermatitis,vitiligo,contact dermatitis and rosacea,by inhibiting the expression of various inflammatory factors via different pathways.This review focuses on research progress in benvitimod for the treatment of dermatoses,with a view to deepening the understanding of its biological effects.

关 键 词：受体 芳香烃 皮肤疾病 银屑病 皮炎 特应性 红斑痤疮 本维莫德 

分 类 号：R75[医药卫生—皮肤病学与性病学]